Prevalence of Somatic and Germline Mutations of Fumarate Hydratase in Uterine Leiomyomas from Young Patients.
Hereditary leiomyomatosis and renal cell cancer (HLRCC) syndrome is caused by germline mutations in the fumarate hydratase (FH) gene. In young women, the syndrome often presents with symptomatic uterine leiomyomas, leading to myomectomy or hysterectomy. In this study, we aim to investigate incidence and mutational profile of FH-negative leiomyomas from young patients, thus allowing for early identification and triage of syndromic patients for surveillance. We evaluated 153 cases of uterine leiomyomas from women up to 30 years old for loss of FH expression by tissue microarray (TMA)-based immunohistochemical staining. Mutational analysis of tumors with loss of FH was carried out by polymerase chain reaction (PCR) amplification of 10 exons within the FH gene and subsequent Sanger sequencing. The status of promoter methylation was assessed by bisulfite sequencing. Loss of FH protein expression was detected in 7 (4.6%) of 153 tested uterine leiomyomas from young patients. All FH-negative leiomyomas displayed staghorn vasculature and fibrillary/neuropil-like cytoplasm. We found 6 (86%) of 7 FH-negative tumors detected by immunohistochemistry harbored FH mutations, and of which, 50% contained germline mutations. Particularly, the germline mutational rate in FH gene was 2.0% (3 of 153 cases). Bisulfite sequencing analysis failed to detect promoter methylation in any of the 7 tumors. Our study showed a relatively high rate of FH germline mutation in FH-negative uterine leiomyomas from patients under 30 years of age. While genetic mutations confer protein expression loss, epigenetic regulation of the FH gene appears to be unrelated to this phenotype.